A novel way to deal with challenge and fear of smoke and gas evacuation during minimal invasive surgery in the current era of COVID-19 pandemic: an ingenuity with review of literature
DOI:
https://doi.org/10.18203/2349-2902.isj20203285Keywords:
COVID-19 pandemic, Minimally invasive surgery, SARS-CoV-2, Smoke evacuationAbstract
Presently COVID-19 viral transmission is a major concern among surgeons worldwide with the use of minimally invasive surgery due to creation of pneumoperitoneum. Due to this proposed concern, we sought to review the scientific data, evaluate the use of MIS and introduction of a novel concept to deal with surgical smoke and gas to prevent the risk of COVID-19 viral transmission. A review of literature of viral transmission in surgery, especially emphasizing the transmission of the COVID-19 was done. We also reviewed other surgical society guidelines and recommendations regarding surgery during this pandemic. Few studies have been performed on viral transmission during surgery, but to date there is not enough evidence to support use of MIS over open surgery or vice versa. There are societal guidelines and expert consensus on the modification of standard practices to minimize the risk of viral transmission. With every day rise in COVID-19 patients therefore consequent increase in surgeries in suspected or confirmed cases and exposure of operative staff to aerosolized particles during MIS, use of surgical smoke and gas evacuation system becomes essential. Although different available filters, insufflation systems are part of the surgical procedures but their cost and availability may concern a COVID-19 fighting or a developing nation. We introduced a novel, simple, easily available and cost effective technique to prevent and reduce the risk of viral transmission in the current era of COVID-19 pandemic.
References
Coronavirus disease (COVID-2019) situation reports. Geneva: World Health Organization, 2020. Available at: https://www.who.int/ emergencies/diseases/novel-coronavirus-2019/situation-reports/.
Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020;323(16):1610-2.
Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. 2020;94:44-8.
Kim JM, Chung YS, Jo HJ, Lee NJ, Kim MS, Woo SH, et al. Identification of coronavirus isolated from a patient in Korea with COVID-19. Osong Public Health Res Perspect. 2020;11(1):3-7.
Wong TW, Lee CK, Tam W, Lau JT, Yu TS, Lui SF, et al. Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg Infect Dis. 2004;10(2):269-76.
Leung WK, To KF, Chan PK, Chan HL, Wu AK, Lee N, et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003;125(4):1011-7.
Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020;158(6):1518-9.
Song Y, Liu P, Shi XL, Chu YL, Zhang J, Xia J, et al. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020;69(6):1143-4.
Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol. 2020;92(6):680-2.
Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831-3.
Capizzi PJ, Clay RP, Battey MJ. Microbiologic activity in laser resurfacing plume and debris. Lasers Surg Med. 1998;23(3):172-4.
Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831-3.
Capizzi PJ, Clay RP, Battey MJ. Microbiologic activity in laser resurfacing plume and debris. Lasers Surg Med. 1998;23(3):172-4.
Hensman C. Chemical composition of smoke produced by high-frequency electrosurgery in a closed gaseous environment. Surg Endosc. 1998;12(8):1017-9.
Johnson GK, Robinson WS. Human immunodeficiency virus‐1 (HIV‐1) in the vapors of surgical power instruments. J Med Virol. 1991;33(1):47-50.
Gloster HM, Roenigk RK. Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts. J Am Acad Dermatol. 1995;32:436-441
Li CI, Pai JY, Chen CH. Characterization of smoke generated during the use of surgical knife in laparotomy surgeries. J Air Waste Manag Assoc. 2020;70(3):324-32.
Annino F, Topazio L, Autieri D, Verdacchi T, De Angelis M, Asimakopoulos AD. Robotic partial nephrectomy performed with Airseal versus a standard CO. Surg Endosc. 2017;31(4):1583-90.
Ripa S, Bruno N, Reder RF, Casillis R, Roth RI. Clinical applications of povidone-iodine as a topical antimicrobial. In: Handbook of topical antimicrobials: industrial applications in consumer products and pharmaceuticals. Marcel Dekker; 2003:77-98.
Fleischer W, Reimer K. Povidone-iodine in antisepsis estate of the art. Dermatology. 1997;195(2):3-9.
Rackur H. New aspects of mechanism of action of Povidone-iodine, J Hosp Infect. 1985;6(A):13-23.
Sriwilaijaroen N, Wilairat P, Hiramatsu H, Takahashi T, Suzuki T, Ito M, et al. Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities. Virol J. 2009;6(1):124.
Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens. Infect Dis Therap. 2018;7(2):249-59.
